Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Number of shares and voting rights as at 28 September 2012



Number of shares and voting rights


Article L.233-8-II of Commercial Law (Code de commerce) and


Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF – Autorité des Marchés Financiers)


Press release


Avignon, October 5th, 2012



28.09.2012





























Total number of outstanding shares forming the capital

- 7,010,924 ordinary shares under ISIN FR0000054694

- 717,155 preferred shares under ISIN FR0010833251

 
 

7,728,079
Total number of outstanding shares forming the capital with voting rights

- 7,010,924 ordinary shares under ISIN FR0000054694



 
7,010,924
Number of shares with double voting rights 215,843
Total number of gross voting rights 7,226,767
 

Number of shares without voting rights

- 3,013 bearer shares in the frame of the liquidity contract

 
 

- 3,013
Total number of exercisable voting rights*  

7,223,754

 

*Real number of voting rights = total number of voting rights – number of shares without voting rights


If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com


Naturex has been listed since October 1996 on NYSE Euronext in Paris, compartment B








NATUREX Number of shares comprising the capital: 7,728,079

- 7,010,924 ordinary shares (ISIN FR0000054694)

- 717,155 preferred shares (ISIN FR0010833251)

Naturex is part of the CAC Small and Gaïa Indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

Naturex has set up a sponsored level I American Depositary Receipt (ADR) programme. Naturex's ADRs are traded over the counter in the United States under the symbol NTUXY.


MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY




About Naturex


NATUREX is a global leader in specialty plant-based natural ingredients.


The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


NATUREX’s head office is based in Avignon, France. The company employs more than 1,300 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland), as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 21 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).


NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.
















> Contacts  
 

Thierry Lambert

Vice-Président et Directeur Général

Tél : +33 (0)4 90 23 96 89

[email protected]

 

 
 
Carole Alexandre

Relations Investisseurs

Tél : +33 (0)4 90 23 78 28

[email protected]
Anne Catherine Bonjour

Relations Presse Actus Finance

Tél : +33 (0)1 53 67 36 93

[email protected]

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :

-

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-29565-2012.11.05-nb-of-shares-and-voting-rights-september-2012.pdf

<!-- 90 -->

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free


<br/><p>Quelle: <a href="http://www.actusnews.com/" target="_blank" rel="nofollow">Actusnews</a></p>
Like: 0
Share

Comments